Similar Items: Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
- Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC)
- Enhancement of immune checkpoint inhibitor efficacy by DHX58+ SELL+ T cells in advanced gastric cancer
- Looking for the elusive lung stem cell niche
- The epidermal growth factor receptor (EGRF) in lung cancer
- Role of WWOX and NF-κB in lung cancer progression
- Electronic health records improve the diagnosis and prognosis of pulmonary fungal infections in lung cancer patients